1.3M XNAS Volume
XNAS 24 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 272,000 | 1,098,478 (3%) | 0% | 0 | Common Stock | |
| Daniel Barber | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 29,307 | 1,069,171 (3%) | 0% | 2.7 | 77,664 | Common Stock |
| Daniel Barber | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 53,998 | 1,015,173 (3%) | 0% | 2.7 | 143,095 | Common Stock |
| Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 408,000 | 408,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Peter Boyd | See Remark | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 6,624 | 311,004 (0%) | 0% | 2.7 | 17,554 | Common Stock |
| Peter Boyd | See Remark | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 40,000 | 40,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Peter Boyd | See Remark | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 7,681 | 303,323 (0%) | 0% | 2.7 | 20,355 | Common Stock |
| Peter Boyd | See Remark | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 80,000 | 317,628 (0%) | 0% | 0 | Common Stock | |
| Lori J. Braender | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 60,000 | 60,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Lori J. Braender | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 110,000 | 423,231 (1%) | 0% | 0 | Common Stock | |
| Lori J. Braender | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 9,592 | 413,639 (1%) | 0% | 2.7 | 25,419 | Common Stock |
| Lori J. Braender | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 10,658 | 402,981 (1%) | 0% | 2.7 | 28,244 | Common Stock |
| Stephen Wargacki | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 65,000 | 65,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Stephen Wargacki | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 115,000 | 376,414 (1%) | 0% | 0 | Common Stock | |
| Stephen Wargacki | Chief Science Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 12,859 | 363,555 (1%) | 0% | 2.6 | 34,076 | Common Stock |
| Stephen Wargacki | Chief Science Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 15,431 | 348,124 (1%) | 0% | 2.6 | 40,892 | Common Stock |
| Stephen Wargacki | Chief Science Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.54 per share. | 07 Mar 2025 | 4,572 | 343,552 (1%) | 0% | 2.5 | 11,613 | Common Stock |
| Cassie Jung | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 40,000 | 40,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Cassie Jung | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 80,000 | 313,066 (0%) | 0% | 0 | Common Stock | |
| Cassie Jung | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 7,361 | 305,705 (0%) | 0% | 2.7 | 19,507 | Common Stock |
| Cassie Jung | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 7,997 | 297,708 (0%) | 0% | 2.6 | 21,192 | Common Stock |
| Cassie Jung | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.54 per share. | 07 Mar 2025 | 2,182 | 295,526 (0%) | 0% | 2.5 | 5,542 | Common Stock |
| Carl N. Kraus | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 70,000 | 321,681 (0%) | 0% | 0 | Common Stock | |
| Carl N. Kraus | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 30,000 | 30,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Carl N. Kraus | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 8,115 | 313,566 (0%) | 0% | 2.7 | 21,505 | Common Stock |
| Sherry Korczynski | SVP Sales and Marketing | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 5,428 | 159,572 (0%) | 0% | 2.6 | 14,384 | Common Stock |
| Sherry Korczynski | SVP Sales and Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 35,000 | 35,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sherry Korczynski | SVP Sales and Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 90,000 | 165,000 (0%) | 0% | 0 | Common Stock | |
| Bratton Douglas K. | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2024 | 40,000 | 199,841 (0%) | 0% | 0 | Common Stock | |
| Cassie Jung | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 4.86 per share. | 26 Nov 2024 | 44 | 0 (0%) | 0% | 4.9 | 214 | Common Stock |
| Carl N. Kraus | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.43 per share. | 09 Aug 2024 | 10,819 | 251,681 (0%) | 0% | 3.4 | 37,109 | Common Stock |
| Gregory B. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 38,000 | 38,000 | - | - | Stock Option (Right to Purchase) | |
| Santo J. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 38,000 | 38,000 | - | - | Stock Option (Right to Purchase) | |
| Timothy E. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 38,000 | 38,000 | - | - | Stock Option (right to purchase) | |
| Marco Taglietti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 38,000 | 38,000 | - | - | Stock Option (Right to Purchase) | |
| Julie Krop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 38,000 | 38,000 | - | - | Stock Option (Right to Purchase) | |
| John S. Cochran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 38,000 | 38,000 | - | - | Stock Option (Right to Purchase) | |
| Sherry Korczynski | SVP Sales and Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 25,000 | 25,000 (0%) | 0% | 0 | Common Stock | |
| Abigail L. Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 57,000 | 57,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Stephen Wargacki | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 10,000 | 267,963 (0%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 15 Mar 2024 | 50,000 | 984,476 (2%) | 0% | 6 | 300,000 | Common Stock |
| Daniel Barber | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 37,938 | 845,364 (2%) | 0% | 4.9 | 185,137 | Common Stock |
| Peter Boyd | See Remark | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 8,370 | 237,628 (0%) | 0% | 4.9 | 40,846 | Common Stock |
| Lori J. Braender | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 10,530 | 313,231 (0%) | 0% | 4.9 | 51,386 | Common Stock |
| Stephen Wargacki | SVP, Research & Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 1,687 | 257,963 (0%) | 0% | 4.9 | 8,233 | Common Stock |
| Stephen Wargacki | SVP, Research & Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 11,269 | 259,650 (0%) | 0% | 4.9 | 54,993 | Common Stock |
| Cassie Jung | SVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 1,132 | 237,754 (0%) | 0% | 4.9 | 5,524 | Common Stock |
| Cassie Jung | SVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 8,300 | 238,886 (0%) | 0% | 4.9 | 40,504 | Common Stock |
| Daniel Barber | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 56,824 | 826,478 (2%) | 0% | 4.9 | 277,301 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 9,645 | 980,726 (2%) | 0% | 4.9 | 47,068 | Common Stock |
| Stephen Wargacki | Chief Science Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 19,505 | 261,414 (0%) | 0% | 4.9 | 95,184 | Common Stock |
| Cassie Jung | SVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 14,120 | 233,066 (0%) | 0% | 4.9 | 68,906 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Sale of securities on an exchange or to another person at price $ 5.19 per share. | 08 Mar 2024 | 25,000 | 1,040,371 (3%) | 0% | 5.2 | 129,685 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 08 Mar 2024 | 5,895 | 1,034,476 (3%) | 0% | 4.9 | 28,768 | Common Stock |
| Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 363,900 | 363,900 | - | - | Non-Qualified Stock Option (right to buy) | |
| Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 242,600 | 883,302 (2%) | 0% | 0 | Common Stock | |
| Peter Boyd | See Remark | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 86,250 | 245,998 (0%) | 0% | 0 | Common Stock | |
| Peter Boyd | See Remark | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 43,125 | 43,125 | - | - | Non-Qualified Stock Option (right to buy) | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 41,250 | 41,250 | - | - | Non-Qualified Stock Option (right to buy) | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 82,500 | 1,065,371 (3%) | 0% | 0 | Common Stock | |
| Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 135,000 | 323,761 (0%) | 0% | 0 | Common Stock | |
| Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 67,500 | 67,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| Carl N. Kraus | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 56,250 | 56,250 | - | - | Non-Qualified Stock Option (right to buy) | |
| Carl N. Kraus | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 112,500 | 262,500 (0%) | 0% | 0 | Common Stock | |
| Kenneth W. Marshall | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2023 | 75,000 | 75,000 | - | - | Performance Stock Units | |
| Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2023 | 223,500 | 223,500 | - | - | Performance Stock Units | |
| Peter Boyd | See Remark | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2023 | 50,000 | 50,000 | - | - | Performance Stock Units | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2023 | 50,000 | 50,000 | - | - | Performance Stock Units | |
| Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2023 | 75,000 | 75,000 | - | - | Performance Stock Units | |
| Stephen Wargacki | SVP, Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2023 | 67,500 | 67,500 | - | - | Performance Stock Units | |
| Cassie Jung | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2023 | 55,000 | 55,000 | - | - | Performance Stock Units | |
| Gregory B. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| Santo J. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| Timothy E. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to purchase) | |
| Marco Taglietti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| Julie Krop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| John S. Cochran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| Kenneth W. Marshall | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 75,000 | 75,000 | - | - | Performance Stock Units | |
| Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 223,500 | 223,500 | - | - | Performance Stock Units | |
| Peter Boyd | See Remark | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 50,000 | 50,000 | - | - | Performance Stock Units | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 50,000 | 50,000 | - | - | Performance Stock Units | |
| Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 75,000 | 75,000 | - | - | Performance Stock Units | |
| Stephen Wargacki | SVP, Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 67,500 | 67,500 | - | - | Performance Stock Units | |
| Cassie Jung | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 55,000 | 55,000 | - | - | Performance Stock Units | |
| Stephen Wargacki | SVP, Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 56,250 | 56,250 | - | - | Non-Qualified Stock Option (right to buy) | |
| Stephen Wargacki | SVP, Research & Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.79 per share. | 10 Mar 2023 | 1,981 | 158,419 (0%) | 0% | 0.8 | 1,572 | Common Stock |
| Stephen Wargacki | SVP, Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 112,500 | 270,919 (0%) | 0% | 0 | Common Stock | |
| Cassie Jung | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 101,250 | 247,186 (0%) | 0% | 0 | Common Stock | |
| Cassie Jung | SVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 10 Mar 2023 | 1,365 | 145,936 (0%) | 0% | 0 | Common Stock | |
| Cassie Jung | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 50,625 | 50,625 | - | - | Non-Qualified Stock Option (right to buy) | |
| Kenneth W. Marshall | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 150,000 | 150,000 (0%) | 0% | 0 | Common Stock | |
| Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 447,000 | 640,702 (1%) | 1% | 0 | Common Stock | |
| Peter Boyd | See Remark | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 100,000 | 159,532 (0%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 100,000 | 982,871 (2%) | 0% | 0 | Common Stock | |
| Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 150,000 | 188,761 (0%) | 0% | 0 | Common Stock | |
| Stephen Wargacki | SVP, Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 135,000 | 161,956 (0%) | 0% | 0 | Common Stock | |
| Cassie Jung | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 110,000 | 146,747 (0%) | 0% | 0 | Common Stock | |
| Kenneth W. Marshall | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2022 | 40,000 | 40,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Peter Boyd | SVP-Bus. Process & Info. Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2022 | 25,000 | 25,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2022 | 40,000 | 40,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2022 | 40,000 | 40,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Kenneth Truitt | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 100,000 | 100,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Timothy E. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2022 | 28,500 | 28,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| Daniel Barber | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 100,000 | 100,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Gregory B. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| Santo J. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| Marco Taglietti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| Julie Krop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| John S. Cochran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) | |
| Peter Boyd | SVP-Bus. Process & Info. Tech. | Purchase of securities on an exchange or from another person at price $ 0.81 per share. | 14 Jun 2022 | 5,000 | 59,532 (0%) | 0% | 0.8 | 4,050 | Common Stock |
| Daniel Barber | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Jun 2022 | 91,743 | 91,743 | - | - | Warrant (Right to Buy) | |
| Daniel Barber | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 08 Jun 2022 | 91,743 | 193,702 (0%) | 0% | 1.0 | 88,073 | Common Stock |
| Peter Boyd | SVP-Bus. Process & Info. Tech. | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 08 Jun 2022 | 2,293 | 54,532 (0%) | 0% | 1.0 | 2,201 | Common Stock |
| Peter Boyd | SVP-Bus. Process & Info. Tech. | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Jun 2022 | 2,293 | 2,293 | - | - | Warrant (Right to Buy) | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Jun 2022 | 45,871 | 45,871 | - | - | Warrant (Right to Buy) | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 08 Jun 2022 | 45,871 | 882,871 (2%) | 0% | 1.0 | 44,036 | Common Stock |
| Lori J. Braender | General Counsel | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 08 Jun 2022 | 13,761 | 38,761 (0%) | 0% | 1.0 | 13,211 | Common Stock |
| Lori J. Braender | General Counsel | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Jun 2022 | 13,761 | 13,761 | - | - | Warrant (Right to Buy) | |
| Theresa Wood | SVP-HR and Org. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 70,000 | 70,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Keith J. Kendall | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 375,000 | 375,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Kenneth W. Marshall | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 80,000 | 80,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Daniel Barber | SVP-Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 225,000 | 225,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Peter Boyd | SVP-Bus. Process & Info. Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 70,000 | 70,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 75,000 | 75,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 160,000 | 160,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Keith J. Kendall | Director, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Aug 2021 | 1,000 | 636,149 (1%) | 0% | - | Common Stock | |
| Keith J. Kendall | Director, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Aug 2021 | 1,000 | 1,000 (0%) | 0% | - | Common Stock | |
| Gregory B. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Purchase) | |
| Nancy S. Lurker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Purchase) | |
| Santo J. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Purchase) | |
| Marco Taglietti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Purchase) | |
| James S. Scibetta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Purchase) | |
| Julie Krop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Purchase) | |
| John S. Cochran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Purchase) | |
| John S. Cochran | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 May 2021 | 37,500 | 99,486 (0%) | 0% | 0 | Common Stock | |
| Douglas K. Bratton | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Mar 2021 | 62,500 | 12,585 (0%) | 0% | 0 | Common Stock | |
| Douglas K. Bratton | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Mar 2021 | 524,675 | 1,688,639 (5%) | 1% | 0 | Common Stock | |
| Douglas K. Bratton | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Mar 2021 | 564,160 | 3,468,747 (10%) | 1% | 0 | Common Stock | |
| Douglas K. Bratton | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Mar 2021 | 97,598 | 2,657,943 (8%) | 0% | 0 | Common Stock | |
| Douglas K. Bratton | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Mar 2021 | 40,404 | 47,051 (0%) | 0% | 0 | Common Stock | |
| Douglas K. Bratton | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Mar 2021 | 2,249,077 | 0 (0%) | 6% | 0 | Common Stock | |
| Douglas K. Bratton | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Mar 2021 | 1,783,578 | 1,948,578 (5%) | 5% | 0 | Common Stock | |
| John S. Cochran | Director | Other type of transaction at price $ 0.00 per share. | 12 Mar 2021 | 19,091 | 136,986 (0%) | 0% | 0 | Common Stock | |
| John S. Cochran | Director | Other type of transaction at price $ 0.00 per share. | 12 Mar 2021 | 8,228 | 106,351 (0%) | 0% | 0 | Common Stock | |
| John S. Cochran | Director | Other type of transaction at price $ 0.00 per share. | 12 Mar 2021 | 23,038 | 98,123 (0%) | 0% | 0 | Common Stock | |
| John S. Cochran | Director | Other type of transaction at price $ 0.00 per share. | 12 Mar 2021 | 11,544 | 117,895 (0%) | 0% | 0 | Common Stock | |
| Marco Taglietti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 28,500 | 28,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| Julie Krop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 28,500 | 28,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| Theresa Wood | SVP-HR and Org. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 27,000 | 27,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Keith J. Kendall | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 250,000 | 250,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Kenneth W. Marshall | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 40,000 | 40,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Daniel Barber | SVP-Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 100,000 | 100,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Peter Boyd | SVP-Bus. Process & Info. Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 35,000 | 35,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 70,000 | 70,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 75,000 | 75,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Sale of securities on an exchange or to another person at price $ 6.75 per share. | 09 Feb 2021 | 23,460 | 837,000 (2%) | 0% | 6.8 | 158,355 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Sale of securities on an exchange or to another person at price $ 6.75 per share. | 09 Feb 2021 | 11,540 | 860,460 (2%) | 0% | 6.8 | 77,895 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Sale of securities on an exchange or to another person at price $ 6.50 per share. | 08 Feb 2021 | 40,792 | 872,000 (2%) | 0% | 6.5 | 265,148 | Common Stock |
| John T. Maxwell | SVP-Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 18 Aug 2020 | 3,000 | 150,614 (0%) | 0% | 8 | 24,000 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 333 | 0 | - | - | Restricted Stock Units | |
| Keith J. Kendall | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.86 per share. | 30 Jun 2020 | 148 | 639,149 (1%) | 0% | 4.9 | 719 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 333 | 639,297 (1%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.86 per share. | 30 Jun 2020 | 94 | 912,792 (2%) | 0% | 4.9 | 457 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 333 | 0 | - | - | Restricted Stock Units | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 333 | 912,886 (2%) | 0% | 0 | Common Stock | |
| Gregory B. Brown | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 14,000 | 14,000 | - | - | Stock Option (Right to Purchase) | |
| Nancy Lurker | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 14,000 | 14,000 | - | - | Stock Option (Right to Purchase) | |
| Santo J. Costa | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 14,000 | 14,000 | - | - | Stock Option (Right to Purchase) | |
| James S. Scibetta | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 14,000 | 14,000 | - | - | Stock Option (Right to Purchase) | |
| Douglas Bratton | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 14,000 | 14,000 | - | - | Stock Option (Right to Purchase) | |
| John Cochran | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 14,000 | 14,000 | - | - | Stock Option (Right to Purchase) | |
| Keith J. Kendall | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 5.11 per share. | 04 Jun 2020 | 50,000 | 638,964 (1%) | 0% | 5.1 | 255,310 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2020 | 14,572 | 0 | - | - | Restricted Stock Units | |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2020 | 14,572 | 695,456 (2%) | 0% | 0 | Common Stock | |
| Keith J. Kendall | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.87 per share. | 31 May 2020 | 6,492 | 688,964 (2%) | 0% | 4.9 | 31,616 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.87 per share. | 31 May 2020 | 4,132 | 912,553 (2%) | 0% | 4.9 | 20,123 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2020 | 14,572 | 916,685 (2%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2020 | 14,572 | 0 | - | - | Restricted Stock Units | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 08 May 2020 | 40,000 | 902,113 (2%) | 0% | 5 | 200,000 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Sale of securities on an exchange or to another person at price $ 4.50 per share. | 29 Apr 2020 | 40,000 | 1,022,113 (3%) | 0% | 4.5 | 180,000 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Sale of securities on an exchange or to another person at price $ 3.70 per share. | 14 Apr 2020 | 40,000 | 982,113 (2%) | 0% | 3.7 | 148,000 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 14 Apr 2020 | 40,000 | 942,113 (2%) | 0% | 4 | 160,000 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.19 per share. | 31 Mar 2020 | 99 | 680,884 (2%) | 0% | 2.2 | 217 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2020 | 329 | 333 | - | - | Restricted Stock Units | |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2020 | 329 | 680,983 (2%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.19 per share. | 31 Mar 2020 | 97 | 1,062,113 (3%) | 0% | 2.2 | 212 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2020 | 329 | 333 | - | - | Restricted Stock Units | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2020 | 329 | 1,062,210 (3%) | 0% | 0 | Common Stock | |
| Theresa Wood | SVP-HR and Org. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2020 | 30,000 | 30,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Keith J. Kendall | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2020 | 225,000 | 225,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ken W Marshall | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2020 | 45,400 | 45,400 | - | - | Non-Qualified Stock Option (right to buy) | |
| Daniel Barber | SVP-Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2020 | 110,000 | 110,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Peter Boyd | SVP-Bus. Process & Info. Tech. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2020 | 50,700 | 50,700 | - | - | Non-Qualified Stock Option (right to buy) | |
| Peter Boyd | SVP-Bus. Process & Info. Tech. | Purchase of securities on an exchange or from another person at price $ 1.50 per share. | 16 Mar 2020 | 2,000 | 52,239 (0%) | 0% | 1.5 | 3,000 | Common Stock |
| John T. Maxwell | SVP-Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2020 | 60,000 | 60,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2020 | 70,000 | 70,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Lori J Braender | SVP, General Counsel | Purchase of securities on an exchange or from another person at price $ 1.54 per share. | 16 Mar 2020 | 14,000 | 25,000 (0%) | 0% | 1.5 | 21,624 | Common Stock |
| Lori J Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2020 | 60,000 | 60,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Gary H. Slatko | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2020 | 50,000 | 50,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2020 | 14,572 | 14,572 | - | - | Restricted Stock Units | |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2020 | 14,572 | 685,383 (2%) | 0% | 0 | Common Stock | |
| Keith J. Kendall | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.73 per share. | 29 Feb 2020 | 4,729 | 680,654 (2%) | 0% | 3.7 | 17,639 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2020 | 14,572 | 1,066,947 (3%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2020 | 14,572 | 14,572 | - | - | Restricted Stock Units | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.73 per share. | 29 Feb 2020 | 5,066 | 1,061,881 (3%) | 0% | 3.7 | 18,896 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.82 per share. | 31 Dec 2019 | 149 | 670,811 (2%) | 0% | 5.8 | 867 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.82 per share. | 31 Dec 2019 | 147 | 1,052,375 (3%) | 0% | 5.8 | 856 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.79 per share. | 30 Nov 2019 | 6,597 | 670,631 (2%) | 0% | 7.8 | 51,391 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.79 per share. | 30 Nov 2019 | 6,544 | 1,052,193 (3%) | 0% | 7.8 | 50,978 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2019 | 329 | 662,806 (2%) | 0% | 0 | Common Stock | |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2019 | 329 | 991 | - | - | Restricted Stock Units | |
| Keith J. Kendall | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.18 per share. | 30 Sep 2019 | 150 | 662,656 (2%) | 0% | 3.2 | 477 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2019 | 329 | 1,044,310 (3%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2019 | 329 | 991 | - | - | Restricted Stock Units | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.18 per share. | 30 Sep 2019 | 145 | 1,044,165 (3%) | 0% | 3.2 | 461 | Common Stock |
| Kenneth W. Marshall | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2019 | 66,000 | 66,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Keith J. Kendall | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.80 per share. | 31 Aug 2019 | 6,676 | 662,477 (2%) | 0% | 3.8 | 25,369 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2019 | 14,572 | 43,716 | - | - | Restricted Stock Units | |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2019 | 14,572 | 669,153 (2%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2019 | 14,572 | 1,050,441 (3%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2019 | 14,572 | 43,716 | - | - | Restricted Stock Units | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.80 per share. | 31 Aug 2019 | 6,460 | 1,043,981 (3%) | 0% | 3.8 | 24,548 | Common Stock |
| Daniel Barber | SVP-Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 3.99 per share. | 27 Aug 2019 | 2,000 | 101,959 (0%) | 0% | 4.0 | 7,980 | Common Stock |
| James S. Scibetta | Director | Purchase of securities on an exchange or from another person at price $ 3.80 per share. | 19 Aug 2019 | 11,310 | 30,735 (0%) | 0% | 3.8 | 43,001 | Common Stock |
| James S. Scibetta | Director | Purchase of securities on an exchange or from another person at price $ 3.81 per share. | 19 Aug 2019 | 900 | 31,635 (0%) | 0% | 3.8 | 3,429 | Common Stock |
| James S. Scibetta | Director | Purchase of securities on an exchange or from another person at price $ 3.77 per share. | 19 Aug 2019 | 10,761 | 19,425 (0%) | 0% | 3.8 | 40,547 | Common Stock |
| Peter Boyd | SVP-Bus. Process & Info. Tech. | Purchase of securities on an exchange or from another person at price $ 3.81 per share. | 12 Aug 2019 | 600 | 50,239 (0%) | 0% | 3.8 | 2,286 | Common Stock |
| Theresa Wood | SVP-HR and Org. Development | Purchase of securities on an exchange or from another person at price $ 3.99 per share. | 09 Aug 2019 | 1,000 | 80,765 (0%) | 0% | 4.0 | 3,990 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 3.70 per share. | 09 Aug 2019 | 1,000 | 653,581 (1%) | 0% | 3.7 | 3,697 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 4.04 per share. | 09 Aug 2019 | 1,000 | 652,581 (1%) | 0% | 4.0 | 4,045 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 09 Aug 2019 | 2,000 | 651,581 (1%) | 0% | 4.0 | 7,990 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 3.92 per share. | 09 Aug 2019 | 1,000 | 649,581 (1%) | 0% | 3.9 | 3,925 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 3.65 per share. | 09 Aug 2019 | 1,000 | 654,581 (1%) | 0% | 3.7 | 3,650 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 3.84 per share. | 09 Aug 2019 | 2,000 | 648,581 (1%) | 0% | 3.8 | 7,680 | Common Stock |
| Lori J. Braender | SVP, General Counsel | Purchase of securities on an exchange or from another person at price $ 4.07 per share. | 09 Aug 2019 | 10,000 | 11,000 (0%) | 0% | 4.1 | 40,747 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2019 | 329 | 646,735 (1%) | 0% | 0 | Common Stock | |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2019 | 329 | 1,320 | - | - | Restricted Stock Units | |
| Keith J. Kendall | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.20 per share. | 30 Jun 2019 | 154 | 646,581 (1%) | 0% | 4.2 | 647 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.20 per share. | 30 Jun 2019 | 149 | 1,035,869 (3%) | 0% | 4.2 | 626 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2019 | 329 | 1,036,018 (3%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2019 | 329 | 1,320 | - | - | Restricted Stock Units | |
| Gregory B. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 13,350 | 13,350 | - | - | Stock Option (Right to Purchase) | |
| Nancy S. Lurker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 13,350 | 13,350 | - | - | Stock Option (Right to Purchase) | |
| Santo J. Costa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 13,350 | 13,350 | - | - | Stock Option (Right to Purchase) | |
| James S. Scibetta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 13,350 | 13,350 | - | - | Stock Option (Right to Purchase) | |
| Douglas K. Bratton | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 13,350 | 13,350 | - | - | Stock Option (Right to Purchase) | |
| John S. Cochran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2019 | 13,350 | 13,350 | - | - | Stock Option (Right to Purchase) | |
| Keith J. Kendall | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.72 per share. | 31 May 2019 | 6,780 | 646,406 (1%) | 0% | 3.7 | 25,222 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2019 | 14,572 | 58,288 | - | - | Restricted Stock Units | |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2019 | 14,572 | 653,186 (1%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2019 | 14,572 | 1,042,280 (3%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2019 | 14,572 | 58,288 | - | - | Restricted Stock Units | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.72 per share. | 31 May 2019 | 6,591 | 1,035,689 (3%) | 0% | 3.7 | 24,519 | Common Stock |
| Daniel Barber | SVP-Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2019 | 50,000 | 50,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2019 | 329 | 1,649 | - | - | Restricted Stock Units | |
| Keith J. Kendall | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. | 31 Mar 2019 | 263 | 638,614 (1%) | 0% | 6.9 | 1,817 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2019 | 329 | 638,877 (1%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2019 | 329 | 1,649 | - | - | Restricted Stock Units | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. | 31 Mar 2019 | 263 | 1,027,708 (3%) | 0% | 6.9 | 1,817 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2019 | 329 | 1,027,971 (3%) | 0% | 0 | Common Stock | |
| Theresa Wood | SVP-HR and Org. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 45,000 | 45,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2019 | 14,572 | 643,273 (1%) | 0% | 0 | Common Stock | |
| Keith J. Kendall | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 325,000 | 325,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2019 | 14,572 | 72,860 | - | - | Restricted Stock Units | |
| Keith J. Kendall | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.05 per share. | 28 Feb 2019 | 4,725 | 638,548 (1%) | 0% | 8.0 | 38,036 | Common Stock |
| Daniel Barber | SVP-Chief Strategy/Dev Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 70,000 | 70,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Peter Boyd | SVP-Operations/Value Delivery | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 30,000 | 30,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| John T. Maxwell | SVP-Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 95,000 | 95,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2019 | 14,572 | 72,860 | - | - | Restricted Stock Units | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.05 per share. | 28 Feb 2019 | 6,721 | 1,027,642 (3%) | 0% | 8.0 | 54,104 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2019 | 14,572 | 1,034,363 (3%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | SVP,Chief Innov/Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 75,000 | 75,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Lori J. Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 100,000 | 100,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Gary H. Slatko | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 75,000 | 75,000 | - | - | Stock Option (Right to Purchase) | |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2018 | 329 | 628,863 (2%) | 0% | 0 | Common Stock | |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2018 | 329 | 1,978 | - | - | Restricted Stock Unit | |
| Keith J. Kendall | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.30 per share. | 31 Dec 2018 | 162 | 628,701 (2%) | 0% | 6.3 | 1,021 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2018 | 329 | 1,978 | - | - | Restricted Stock Unit | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2018 | 329 | 1,019,953 (4%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.30 per share. | 31 Dec 2018 | 162 | 1,019,791 (4%) | 0% | 6.3 | 1,021 | Common Stock |
| Daniel Barber | SVP-Chief Strategy/Dev Officer | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 10 Dec 2018 | 1,000 | 99,959 (0%) | 0% | 8 | 8,000 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Purchase of securities on an exchange or from another person at price $ 7.78 per share. | 10 Dec 2018 | 1,000 | 1,019,624 (4%) | 0% | 7.8 | 7,780 | Common Stock |
| John T. Maxwell | SVP-Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 8.87 per share. | 06 Dec 2018 | 5,000 | 153,614 (0%) | 0% | 8.9 | 44,350 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Purchase of securities on an exchange or from another person at price $ 8.69 per share. | 06 Dec 2018 | 2,000 | 1,018,624 (4%) | 0% | 8.7 | 17,380 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2018 | 14,572 | 87,432 | - | - | Restricted Stock Unit | |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2018 | 14,572 | 635,711 (2%) | 0% | 0 | Common Stock | |
| Keith J. Kendall | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.59 per share. | 30 Nov 2018 | 7,177 | 628,534 (2%) | 0% | 8.6 | 61,650 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2018 | 14,572 | 1,023,801 (4%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2018 | 14,572 | 87,432 | - | - | Restricted Stock Unit | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.59 per share. | 30 Nov 2018 | 7,177 | 1,016,624 (4%) | 0% | 8.6 | 61,650 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 9.87 per share. | 27 Nov 2018 | 1,000 | 621,139 (2%) | 0% | 9.9 | 9,870 | Common Stock |
| Lori J Braender | General Counsel | Purchase of securities on an exchange or from another person at price $ 10.57 per share. | 27 Nov 2018 | 1,000 | 1,000 (0%) | 0% | 10.6 | 10,570 | Common Stock |
| Theresa Wood | SVP-HR and Org. Development | Purchase of securities on an exchange or from another person at price $ 10.34 per share. | 26 Nov 2018 | 500 | 79,765 (0%) | 0% | 10.3 | 5,170 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 9.90 per share. | 21 Nov 2018 | 1,950 | 620,139 (2%) | 0% | 9.9 | 19,305 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 10.17 per share. | 21 Nov 2018 | 6,000 | 618,189 (2%) | 0% | 10.2 | 61,020 | Common Stock |
| Ken W Marshall | Commercial Leader | Purchase of securities on an exchange or from another person at price $ 10.15 per share. | 21 Nov 2018 | 1,445 | 1,445 (0%) | 0% | 10.2 | 14,667 | Common Stock |
| Peter Boyd | SVP-Operations/Value Delivery | Purchase of securities on an exchange or from another person at price $ 9.98 per share. | 21 Nov 2018 | 200 | 49,639 (0%) | 0% | 10.0 | 1,996 | Common Stock |
| John T. Maxwell | SVP-Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 9.80 per share. | 21 Nov 2018 | 10,000 | 148,614 (0%) | 0% | 9.8 | 98,000 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Purchase of securities on an exchange or from another person at price $ 10.25 per share. | 21 Nov 2018 | 1,000 | 1,009,229 (4%) | 0% | 10.3 | 10,250 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2018 | 329 | 1,008,391 (4%) | 0% | 0 | Common Stock | |
| Keith J. Kendall | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.51 per share. | 30 Sep 2018 | 162 | 1,008,229 (4%) | 0% | 17.5 | 2,837 | Common Stock |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2018 | 329 | 2,307 | - | - | Restricted Stock Unit | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.51 per share. | 30 Sep 2018 | 162 | 1,008,229 (4%) | 0% | 17.5 | 2,837 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2018 | 329 | 2,307 | - | - | Restricted Stock Unit | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2018 | 329 | 1,008,391 (4%) | 0% | 0 | Common Stock | |
| Lori J Braender | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2018 | 85,000 | 85,000 | - | - | Stock Option (Right to Purchase) | |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2018 | 14,572 | 1,014,572 (4%) | 0% | 0 | Common Stock | |
| Keith J. Kendall | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2018 | 14,572 | 102,004 | - | - | Restricted Stock Unit | |
| Keith J. Kendall | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.01 per share. | 31 Aug 2018 | 6,510 | 1,008,062 (4%) | 0% | 18.0 | 117,245 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2018 | 14,572 | 1,014,572 (4%) | 0% | 0 | Common Stock | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.01 per share. | 31 Aug 2018 | 6,510 | 1,008,062 (4%) | 0% | 18.0 | 117,245 | Common Stock |
| A. Mark Schobel | Chief Innovation/Tech Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2018 | 14,572 | 102,004 | - | - | Restricted Stock Unit | |
| Keith J. Kendall | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2018 | 2,636 | 2,636 | - | - | Restricted Stock Unit | |
| Keith J. Kendall | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2018 | 28,043 | 28,043 | - | - | Stock Option (Right to Purchase) | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2018 | 2,636 | 2,636 | - | - | Restricted Stock Unit | |
| A. Mark Schobel | Chief Innovation/Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2018 | 28,043 | 28,043 | - | - | Stock Option (Right to Purchase) | |
| Douglas Bratton | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 24 Jul 2018 | 165,000 | 165,000 (0%) | 0% | 15 | 2,475,000 | Common Stock |